E. Claiborne Robins Company, Inc. v. Teva Pharmaceuticals Industries, Limited
| E. CLAIBORNE ROBINS COMPANY, INC. |
| TEVA PHARMACEUTICALS INDUSTRIES, LIMITED, TEVA PHARMACEUTICALS USA, INCORPORATED, TEVA PHARMACEUTICALS INTERNATIONAL GMBH and CEPHALON, INC. |
| 22-1390 |
| April 11, 2022 |
| U.S. Court of Appeals, Fourth Circuit |
| Other Contract Actions |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 2, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 14 APPEARANCE OF COUNSEL by Devora W. Allon for Cephalon, Inc., Teva Pharmaceuticals Industries, Limited, Teva Pharmaceuticals International GmbH and Teva Pharmaceuticals USA, Incorporated. [1001155614] [22-1390] Devora Allon [Entered: 05/02/2022 02:31 PM] |
| Filing 13 COURT ORDER filed granting Motion for abeyance [ # 7 ]. Case 22-1390 placed in abeyance pending settlement discussions. Status Report due 07/27/2022. Copies to all parties. [1001153346] [22-1390] JSN [Entered: 04/27/2022 04:03 PM] |
| Filing 12 Initial mediation conference scheduled. [1001152607] [22-1390] LHP [Entered: 04/26/2022 04:02 PM] |
| Filing 11 DISCLOSURE STATEMENT by Cephalon, Inc.. Was any question on Disclosure Form answered yes? Yes [1001151476] [22-1390] Maurice Mullins [Entered: 04/25/2022 03:13 PM] |
| Filing 10 DISCLOSURE STATEMENT by Teva Pharmaceuticals International GmbH. Was any question on Disclosure Form answered yes? Yes [1001151474] [22-1390] Maurice Mullins [Entered: 04/25/2022 03:12 PM] |
| Filing 9 DISCLOSURE STATEMENT by Teva Pharmaceuticals Industries, Limited. Was any question on Disclosure Form answered yes? Yes [1001151473] [22-1390] Maurice Mullins [Entered: 04/25/2022 03:11 PM] |
| Filing 8 DISCLOSURE STATEMENT by Teva Pharmaceuticals USA, Incorporated. Was any question on Disclosure Form answered yes? Yes [1001151472] [22-1390] Maurice Mullins [Entered: 04/25/2022 03:10 PM] |
| Filing 7 MOTION by E. Claiborne Robins Company, Inc. to suspend briefing , to place case in abeyance.. Date and method of service: 04/25/2022 ecf. [1001151399] [22-1390] Joseph Rainsbury [Entered: 04/25/2022 02:06 PM] |
| Filing 6 DISCLOSURE STATEMENT by E. Claiborne Robins Company, Inc.. Was any question on Disclosure Form answered yes? No [1001151389] [22-1390] Joseph Rainsbury [Entered: 04/25/2022 01:58 PM] |
| Filing 5 DOCKETING STATEMENT by E. Claiborne Robins Company, Inc... [1001151383] [22-1390] Joseph Rainsbury [Entered: 04/25/2022 01:56 PM] |
| Filing 4 APPEARANCE OF COUNSEL by Joseph M. Rainsbury for E. Claiborne Robins Company, Inc.. [1001151374] [22-1390] Joseph Rainsbury [Entered: 04/25/2022 01:50 PM] |
| Filing 3 APPEARANCE OF COUNSEL by Maurice Mullins Jr for Cephalon, Inc., Teva Pharmaceuticals Industries, Limited, Teva Pharmaceuticals International GmbH and Teva Pharmaceuticals USA, Incorporated. [1001151208] [22-1390] Maurice Mullins [Entered: 04/25/2022 11:37 AM] |
| Filing 2 DOCKETING NOTICE issued Re: [ # 1 ] case. Originating case number: 3:18-cv-00827-DJN-EWH. Mailed to: Brian Sieve. [1001143330] [22-1390] JSN [Entered: 04/11/2022 11:12 AM] |
| Filing 1 Case docketed. Originating case number: 3:18-cv-00827-DJN-EWH. Case manager: JeffNeal. [1001143325] [22-1390] JSN [Entered: 04/11/2022 11:06 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
